SII seeks permission for phase-3 study of Covid vaccine Covovax as booster dose in adults, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

Serum Institute of India has sought permission from India’s drug regulator to conduct a phase-3 study of its Covid-19 vaccine Covovax as a booster dose in adults, official sources said on Sunday., Serum Institute of India has sought permission from India’s drug regulator to conduct a phase-3 study of its Covid-19 vaccine Covovax as a booster dose in adults, official sources said on Sunday., , Read More